Skipper Bio Med
@SkipperBioMed
Skipper Bio Med is a charitable research consultancy that offers services to assist the preclinical development of theranostics for lung or pancreas cancer
Join @DanaFarber's Brian Wolpin, MD, MPH, of @DanaFarber_Hale for a discussion on the latest clinical trial research and what's on the horizon in treating #PancreaticCancer. Free virtual event hosted by @PanCAN on Thur 1/30 at 2pm ET. RSVP today: bit.ly/42gjjvC
Research into genetic mutations in pancreatic cancer is leading to more targeted treatments and improved patient outcomes. Scientists worldwide are advancing our understanding and developing promising new therapies. bit.ly/3DKmmC8
🎉 Big news! We’ve treated our first participant with PTM-101, an absorbable, long-lasting high-dose chemotherapy patch, in our clinical trial for #PDAC. It’s a huge step toward powerful, localized cancer care for solid #tumors. 🧬 🔗 Full release: businesswire.com/news/home/2025…
We are proud to sponsor this panel discussion on July 10 hosted by @PanCAN President and CEO @JulieFleshman to share information about the impactful resources offered through the PanCAN Patient Services program to support the #pancreaticcancer community: pancan.org/facing-pancrea…
PanCAN Patient Services is a lifeline for people facing #pancreaticcancer. Every call or email we receive, our Case Managers are there, ready to provide support, offer resources and more — often becoming a trusted partner for patients and families as they navigate this…
Our deep knowledge of immune biology is complemented by our extensive drug discovery and development expertise. $SONN #Oncology #SolidTumors
Our Chief Scientific and Medical Officer, Dr. @ABerkenblit, and Chief Business Officer, Sudheer Doss recently sat down with Rafael Rosengarten of Genialis for the Talking Precison Medicine Podcast. During the episode, they shared how PanCAN is working across research, clinical…
💜 Fighting for early diagnosis! Our founder and spokesperson Ali Stunt spoke at the European Parliament's PANCAID event, advocating for research to develop early detection tools for pancreatic cancer. Let's drive change together. 🔗 Read more: pancreaticcanceraction.org/news/fighting-…
This week, I visited Capitol Hill to advocate for federal funding for #pancreaticcancer research with @PanCAN President & CEO @JulieFleshman. Increased, sustained investment is critical to accelerating progress and improving patient outcomes.
Cuts to federally funded biomedical research put progress at risk. Pancreatic cancer patients can’t afford to wait. We stand with pancreatic cancer patients, their families and the research community. Learn more and take action at pcan.at/vl3moc
Excited to get this collaborative publication out with David Lyden to determine the mechanism by which cancer patients, especially pancreatic cancer patients, get venous thromboembolism via exosome-based expression of integrin beta 2. Check the paper out: bit.ly/4hy71nr
We are excited to share that we have formed a new partnership with @SkipperBioMed See Skipper Bio for the webinar details and link: linkedin.com/posts/skipper-…
We are excited to announce a partnership with the Freemind Group! They are highly experienced in securing non-dilutive funding for both academic researchers and companies Tune in to the webinar on Feb 5 at 10 am ET (link below). #cancer #grants #research zoom.us/j/98311229799
IMM-1-104 Phase 2a #PancreaticCancer data updates in combo with chemo were highlighted this week in @cure_today. Read the full article “IMM-1-104 Treatment May Improve Responses in Pancreatic Cancer” here: buff.ly/3CkKlHP $IMRX
January is National #PancreaticCancer #ClinicalTrialsAwarenessMonth! Head over to @PanCan to learn more and register for their free virtual event “Clinical Trials at the Leading Edge of Progress” on Jan 30: buff.ly/4gaiRT5
Detecting #pancreaticcancer early is crucial and significantly improves survival rates. We're committed to the fight against pancreatic cancer by funding innovative research focused on #earlydetection. 💜 Learn more about our mission & initiatives here: ow.ly/Knxi50UChir
Yesterday, #CPRIT awarded Marker Therapeutics, Inc. a $9.5 million grant to develop a treatment to use the patients' own immune system to help fight metastatic pancreatic cancer (mPC). #WorldPancreaticCancerDay #TexansConquerCancer
#HelloPancreas! 💜 It's World Pancreatic Cancer Day—a day to spread awareness about #PancreaticCancer risks & symptoms. You can help make a difference! Learn more at Lustgarten.org/PCAM @worldpcc #WPCD
What a great conference @LSciNation #RESIBoston last month. The exhibit area was buzzing and the investor 1-1s seemed to be at an all time high. And of course...the Innovator's Pitch Challenges (IPC) were the highlight including @AmpSciences taking first place in IPC!
We are having a fantastic time at #RESIBoston! What are you enjoying most about your time at this dynamic event? @AmpSciences @ditcaldwell @bloomertech @achongr @LSciNation #LifeScience #Healthcare
IT'S WORLD PANCREATIC CANCER DAY! 💜📣🎗 Let's turn the world purple today to show support for those facing this disease! Here's how you can join in: 📱Put on your best purple and post on social media! Don't forget to tag @PanCAN and #PanCANawareness 💌 SHARE this post with…
